Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi?
It is generally believed that the invasion of hepatocellular carcinoma (HCC) into the biliary tree ultimately leads to the formation of bile duct tumor thrombi (BDTT). However, recent studies revealed that primary tumor might be small, even undetectable, and there was no histopathologic evidence of direct tumor invasion into bile duct wall in some patients. During the last decade, efforts on stem cell biology may shed light on the pathogenesis of BDTT. Presently, accumulating evidence supports the following notions: (1) the canals of Hering (CoH) are the most likely origin of liver stem/progenitor cells (LSPCs) in adult livers; (2) similar signalling pathways may regulate self-renewal in LSPCs and liver cancer cells, and a substantial proportion of liver tumors may often originate from the transformation of LSPCs; and (3) liver cancer contains rare cells with stem cell-like properties, which could derive from malignant transformation of LSPCs. Herein, we propose that HCC with BDTT, especially with small or undetectable primary lesion and/or no histopathologic evidence for bile duct invasion, might arise from LSPCs residing in the CoH and, possibly, some primary lesions are formed firstly within the intrahepatic biliary tree. When "tumor thrombi" extends mainly along bile duct, there might be "BDTT" alone; when it invades into surrounding parenchyma, there might often be small "primary tumor" with "BDTT". If this holds true, the putative type may be a particular subset of HCC, and most importantly it would facilitate our understanding of stem-cell origin of HCC.
Peng
Ningfu
N
Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, 6 Shuang-yong Road, Nanning, Guangxi Province, 530021, China.
Li
Lequn
L
Cai
Xiang
X
Tan
Shaozao
S
Wu
Ting
T
D000818:Animals; D001650:Bile Duct Neoplasms / Q000473:pathology* / Q000556:secondary; D001653:Bile Ducts, Intrahepatic / Q000473:pathology*; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000473:pathology*; D006801:Humans; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000150:complications / Q000473:pathology*; D008954:Models, Biological; D014411:Neoplastic Stem Cells / Q000473:pathology*
Dis Markers. 2008;24(4-5):223-9
18525116
Gut. 2010 Feb;59(2):247-57
19880964
Cancer Res. 2007 Nov 15;67(22):10831-9
18006828
Nat Med. 2006 Apr;12(4):410-6
16532004
Eur J Cancer. 2010 Apr;46(6):1056-61
20202823
Int J Gastrointest Cancer. 2006;37(1):27-34
17290078
J Hepatobiliary Pancreat Surg. 2007;14(2):204-9
17384916
World J Gastroenterol. 2005 Jul 7;11(25):3966-9
15991304
Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G859-70
16322088
Hepatology. 1999 Dec;30(6):1425-33
10573521
Hepatogastroenterology. 1994 Aug;41(4):349-54
7959570
Surgery. 2000 Nov;128(5):779-83
11056440
Histopathology. 1996 Apr;28(4):291-9
8732337
J Cancer Res Clin Oncol. 2008 May;134(5):535-41
17917742
Cancer Res. 2006 May 1;66(9):4553-7
16651403
Dig Liver Dis. 2009 Jul;41(7):455-62
19403350
J Clin Invest. 2006 Jan;116(1):249-60
16395407
Gastroenterology. 2009 Mar;136(3):1012-24
19150350
Am J Surg Pathol. 2001 Nov;25(11):1388-96
11684955
Surgery. 2001 Jun;129(6):692-8
11391367
Liver Int. 2009 Aug;29(7):955-65
19490415
Hepatology. 2010 Apr;51(4):1401-9
20054870
J Cancer Res Clin Oncol. 2009 Aug;135(8):1073-80
19294418
J Pathol. 1997 Mar;181(3):330-7
9155721
Gastroenterology. 2007 Jun;132(7):2542-56
17570225
Cancer Res. 2008 Jun 1;68(11):4287-95
18519688
Histopathology. 2008 Jan;52(2):224-32
18184271
Med Chir Dig. 1975;4(5-6):267-70
173942
Stem Cells. 2006 Aug;24(8):1852-8
16627685
Environ Health Perspect. 1993 Dec;101 Suppl 5:15-26
7516873
Br J Cancer. 2009 Jun 2;100(11):1765-70
19436294
Hepatology. 2009 May;49(5):1655-63
19309719
J Hepatol. 2000 Jul;33(1):76-84
10905589
Hepatology. 1992 Dec;16(6):1327-33
1280243
Langenbecks Arch Surg. 2009 Nov;394(6):1033-9
19421771
World J Surg. 2004 May;28(5):471-5
15085398
Hepatology. 2009 Sep;50(3):992-3
19714715
Carcinogenesis. 2002 Mar;23(3):435-45
11895858
Hepatology. 2006 Jul;44(1):240-51
16799977
J Gastroenterol. 2002 Jan;37(1):55-8
11824802
Nature. 2001 Nov 1;414(6859):105-11
11689955
Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1320-1
19826380
Int J Clin Pract. 2008 Aug;62(8):1212-8
18479363
Eur J Radiol. 2010 Oct;76(1):103-9
19501994
Hepatol Res. 2005 May;32(1):52-7
15888382
Hum Pathol. 2009 Sep;40(9):1304-11
19386347
J Hepatol. 2010 Jan;52(1):117-29
19913937
J Clin Oncol. 2008 Jun 10;26(17):2800-5
18539957
Hepatology. 2008 Jan;47(1):288-95
17929301
Gastroenterology. 2007 Sep;133(3):937-50
17673212
World J Gastroenterol. 2004 May 15;10(10):1397-401
15133842
Cancer Res. 2008 Mar 1;68(5):1451-61
18316609
Arch Med Res. 2007 Aug;38(6):612-20
17613352
Cancer Sci. 2004 Jul;95(7):592-5
15245596
Gastroenterology. 2007 Nov;133(5):1579-91
17983805
Hepatology. 2001 Mar;33(3):738-50
11230756
Ann N Y Acad Sci. 2009 Feb;1155:206-21
19250206
Intern Med. 2006;45(5):229-33
16595985
Cancer. 1982 May 15;49(10):2144-7
6280834